MetLife Investment Management, LLC
Position in MRVI — Maravai Lifesciences Holdings, Inc.
CIK 1529735
Whippany, NJ
Position in MRVI
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$151,654
+$10,770 QoQ
Shares Held
53,588
+23.6% QoQ
Ownership
0.021%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
18 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in MRVI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026MetLife Investment Management, LLC holds $374,503,407 across 207 Biotechnology names. MRVI ranks #171 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
70,804 | $31,616,818 | |
| 2 | PRAX |
Praxis Precision Medicines, Inc.
|
80,930 | $26,074,836 | |
| 3 | AXSM |
Axsome Therapeutics, Inc.
|
152,645 | $25,800,057 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
|
374,931 | $24,231,790 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
23,567 | $18,208,806 | |
| 6 | FTRE |
Fortrea Holdings Inc.
|
1,805,184 | $17,004,833 | |
| 7 | ADMA |
Adma Biologics, Inc.
|
1,738,062 | $15,659,938 | |
| 8 | VRDN |
Viridian Therapeutics, Inc.DE
|
708,527 | $13,858,788 |
All Filings in MRVI
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $151,654 | 53,588 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $140,884 | 43,349 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $168,509 | 58,714 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $184,815 | 76,687 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $103,326 | 46,754 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $408,226 | 74,904 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $537,956 | 64,736 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $202,341 | 28,260 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $41,347 | 4,769 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $31,145 | 4,755 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $48,250 | 4,825 | Shares | Defined | 2024-05-09 | |
| 2023-06-30 | $59,937 | 4,822 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $93,208 | 6,653 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $94,989 | 6,638 | Shares | Defined | 2023-03-23 | |
| 2022-09-30 | $173,910 | 6,812 | Shares | Defined | 2023-03-23 | |
| 2022-06-30 | $193,386 | 6,807 | Shares | Defined | 2023-03-23 | |
| 2022-03-31 | $250,452 | 7,101 | Shares | Defined | 2023-03-23 | |
| 2021-03-31 | $13,543 | 380 | Shares | Defined | 2023-03-23 | |
| No filing history on record for this holder in this stock. | ||||||